High serum level of procollagen type III amino-terminal peptide contributes to the efficacy of spironolactone and angiotensin-converting enzyme inhibitor therapy on left ventricular hypertrophy in essential hypertensive patients

Hypertension Research

Volumn 24, Issue 2, 2001, Pages 99-104

  Sato, A ^a   Takane, H ^a   Saruta, T ^a  

^a Mito Red Cross Hospital   (Japan)

Author keywords

Angiotensin converting enzyme inihibitor; Cardiac fibrosis; Essential hypertension; Mineralocorticoid receptor antagonist; Serum PIIINP

Indexed keywords

ALDOSTERONE; COLLAGEN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; MINERALOCORTICOID RECEPTOR; PROCOLLAGEN TYPE 3 AMINOPROPEPTIDE; SPIRONOLACTONE; TRANDOLAPRIL;

ADULT; ALDOSTERONE BLOOD LEVEL; ARTICLE; BLOOD PRESSURE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; ESSENTIAL HYPERTENSION; FEMALE; HEART LEFT VENTRICLE HYPERTROPHY; HUMAN; MALE; PROTEIN BLOOD LEVEL; PROTEIN METABOLISM; RECEPTOR BLOCKING;

ADULT; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; DIURETICS; FEMALE; HUMANS; HYPERTENSION; HYPERTROPHY, LEFT VENTRICULAR; INDOLES; MALE; MIDDLE AGED; PEPTIDE FRAGMENTS; PROCOLLAGEN; SPIRONOLACTONE; TREATMENT OUTCOME;

EID: 0035027569     PISSN: 09169636     EISSN: None     Source Type: Journal    
DOI: 10.1291/hypres.24.99     Document Type: Article

References (29)

1. Aldosterone, salt and cardiac fibrosis
2. Mineralocorticoid excess, dietary sodium and myocardial fibrosis
3. Increased cardiac type I and type III collagen mRNA in aldosterone-salt hypertension
4. The renin-angiotensin-aldosterone system in experimental mineralocortiocid-salt-induced cardiac fibrosis
5. Anti-aldosterone treatment and the prevention of myocardial fibrosis in primary and secondary hyperaldosteronism
6. Influence of arterial blood pressure and aldosterone on left ventricular hypertrophy in moderate essential hypertension
7. Aldosterone escape during angiotensin-converting enzyme inhibitor therapy in essential hypertensive patients with left ventricular hypertrophy
8. Involvement of aldosterone in left ventricular hypertrophy of patients with end-stage renal failure treated with hemodialysis
9. The effect of spironolactone on morbidity and mortality in patients with severe heart failure
10. Effects of spironolactone and angiotensin-converting enzyme inhibitor on left ventricular hypertrophy in patients with essential hypertension
11. Serum aminoterminal type III procollagen peptide reflects repair after acute myocardial infarction
12. Increased serum concentrations of procollagen peptides in essential hypertension: Relation to cardiac alterations
13. Collagen type IV and procollagen type III during granulation tissue formation: A serological, biochemical, immunohistochemical and morphometrical study on the viscose cellulose sponge rat model
14. Plasma aldosterone concentrations are not related to the degree of angiotensin-converting enzyme inhibition in essential hypertensive patients
15. The Committee on M-Mode Standardization of the American Society of Echocardiography: Recommendations regarding quantitation in M-mode echocardiography: Results of a survey of echocardiographic measurements
16. Echocardiographic determination of left ventricular mass in man: Anatomic validation of the method
17. Measuring extracellular matrix turnover in the serum of patients with idiopathic or ischemic dilated cardiomyopathy and impact on diagnosis and prognosis
18. Treatment with lisinopril normalizes serum concentrations of procollagen type III amino-terminal peptide in patients with essential hypertension
19. Aldosterone and cardiac fibrosis: In vitro studies
20. Does aldosterone-induced cardiac fibrosis involve direct effects on cardiac fibrosis?
21. Cardiac hypertrophy: Mechanical, neural and endocrine dependence
22. Reversal of left ventricular hypertrophy in hypertensive patients: A metaanalysis of 109 treatment studies
23. Differential effects of angiotensin II and aldosterone on cardiovascular hypertrophy
24. The regression of left ventricular hypertrophy by imidapril and the reduction of serum procollagen type III amino-terminal peptide in hypertensive patients
25. Aldosterone blockade reduces vascular collagen turnover, improves heart rate variability and reduces early morning rise in heart rate in heart failure patients
26. High glucose stimulates aldosterone-induced hypertrophy via type I mineralocorticoid receptors in neonatal rat cardiomyocytes
27. Myocardial production of aldosterone and corticosterone in the rat: Physiological regulation
28. Activation of cardiac aldosterone production in rat myocardial infarction: Effect of angiotensin II receptor blockade and role in cardiac fibrosis
29. Prevention of aortic fibrosis by spironolactone in spontaneously hypertensive rats